Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Addex Therapeutics Net Cash Flow 2021-2025 | ADXN

Addex Therapeutics net cash flow from 2021 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
  
Addex Therapeutics Annual Net Cash Flow
(Millions of US $)
2024 $-1
2023 $-3
2022 $-14
2021 $2
2020 $-14
2019 $N/A
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.010B $0.000B
Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.235B 30.10
Zoetis (ZTS) United States $69.920B 26.09
Takeda Pharmaceutical (TAK) Japan $47.952B 9.54
Daiichi Sankyo, - (DSNKY) Japan $40.710B 20.86
BeOne Medicines - (ONC) Cayman Islands $26.413B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.125B 0.00
Summit Therapeutics (SMMT) United States $16.792B 0.00
Merck (MKKGY) Germany $16.549B 12.13
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $13.099B 11.59
Neurocrine Biosciences (NBIX) United States $12.656B 43.35
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.093B 0.00
Stevanato Group S.p.A (STVN) Italy $7.374B 45.09
Corcept Therapeutics (CORT) United States $7.163B 58.23
Ionis Pharmaceuticals (IONS) United States $6.650B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.421B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.297B 0.00
Hypermarcas (HYPMY) Brazil $3.179B 20.91
Crinetics Pharmaceuticals (CRNX) United States $2.721B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.636B 14.25
Catalyst Pharmaceuticals (CPRX) United States $2.555B 8.95
NewAmsterdam Pharma (NAMS) Netherlands $2.185B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.833B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.819B 0.00
ARS Pharmaceuticals (SPRY) United States $1.678B 0.00
Endo (NDOI) United States $1.622B 0.00
Ocular Therapeutix (OCUL) United States $1.531B 0.00
Evotec AG (EVO) Germany $1.484B 0.00
Guardian Pharmacy Services (GRDN) United States $1.313B 0.00
Harrow (HROW) United States $1.150B 0.00
Ardelyx (ARDX) United States $1.041B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.009B 20.19
Verve Therapeutics (VERV) United States $0.995B 0.00
Collegium Pharmaceutical (COLL) United States $0.993B 5.36
Enliven Therapeutics (ELVN) United States $0.961B 0.00
Akebia Therapeutics (AKBA) United States $0.953B 0.00
Dyne Therapeutics (DYN) United States $0.930B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.860B 0.00
Cronos Group (CRON) Canada $0.787B 0.00
KalVista Pharmaceuticals (KALV) United States $0.749B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Elite Pharmaceuticals (ELTP) United States $0.661B 0.00
Zevra Therapeutics (ZVRA) United States $0.616B 0.00
Relay Therapeutics (RLAY) United States $0.609B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.598B 13.01
Theravance Biopharma (TBPH) United States $0.566B 0.00
Xencor (XNCR) United States $0.565B 0.00
Bioventus (BVS) United States $0.560B 14.21
Organogenesis (ORGO) United States $0.539B 0.00
Oruka Therapeutics (ORKA) United States $0.498B 0.00
Siga Technologies (SIGA) United States $0.481B 10.05
Tourmaline Bio (TRML) United States $0.410B 0.00
Savara (SVRA) United States $0.404B 0.00
AleAnna (ANNA) United States $0.389B 0.00
Aquestive Therapeutics (AQST) United States $0.368B 0.00
Altimmune (ALT) United States $0.359B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.10
Heron Therapeutics (HRTX) United States $0.328B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 27.15
Nektar Therapeutics (NKTR) United States $0.291B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.261B 0.00
OmniAb (OABI) United States $0.228B 0.00
Nanobiotix S.A (NBTX) France $0.226B 0.00
Esperion Therapeutics (ESPR) United States $0.220B 0.00
MediWound (MDWD) Israel $0.208B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
4D Molecular Therapeutics (FDMT) United States $0.183B 0.00
Liminatus Pharma (LIMN) United States $0.180B 0.00
ProKidney (PROK) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Galectin Therapeutics (GALT) United States $0.136B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Champions Oncology (CSBR) United States $0.123B 20.20
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Protara Therapeutics (TARA) United States $0.108B 0.00
Nutriband (NTRB) United States $0.094B 0.00
Cassava Sciences (SAVA) United States $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.075B 0.00
VAXART, INC (VXRT) United States $0.073B 0.00
Achieve Life Sciences (ACHV) Canada $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.068B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Metagenomi (MGX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.051B 0.00
Jupiter Neurosciences (JUNS) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 33.78
ElectroCore (ECOR) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
Vivos Therapeutics (VVOS) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 2.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.09
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00